Caricamento...
A novel anti-IL4Rα nanoparticle efficiently controls lung inflammation during asthma
Drug resistance and the harmful side effects accompanying the prolonged corticosteroid treatment of chronic pulmonary diseases prompted the development of more specific anti-inflammatory approaches. Several strategies aiming to block IL4Rα, the receptor for a key pro-inflammatory pathway, were inves...
Salvato in:
| Pubblicato in: | Exp Mol Med |
|---|---|
| Autori principali: | , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Nature Publishing Group
2016
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5099422/ https://ncbi.nlm.nih.gov/pubmed/27713399 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/emm.2016.89 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|